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Summary
Objective: The purpose of our study was to assess the diagnostic accuracy of multislice com-
puted tomography (MSCT) for the identiﬁcation and quantiﬁcation of mitral valve regurgitation
in comparison with transthoracic echocardiography (TTE).
Methods: Twenty-six patients (15 females, 11 males with a mean age of 44.6± 14.1 years) who
were in follow-up with the diagnosis of mitral regurgitation and those who were referred for
MSCT were enrolled. MSCT results were compared with TTE measurements.
Results: The mean effective mitral regurgitant oriﬁce area at MSCT was 23.1± 13.0mm2 and
at echocardiography was 24.4± 16.0mm2. Bland—Altman analysis showed good agreement
between the two imaging methods.
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ntroductionitral regurgitation is a growing public health problem in
eveloping countries. Although patients with mitral regur-
itation are usually asymptomatic, mitral regurgitation may
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rogress insidiously, causing left ventricular dysfunction
efore symptoms have developed. Therefore some authors
dvocate mitral valve surgery even for asymptomatic severe
itral regurgitation [1]. The timing of the surgery mainly
epends on the severity of the regurgitation. Transtho-
acic echocardiography (TTE) is the standard diagnostic tool
or the evaluation of the severity of mitral regurgitation.
owever TTE has technical limitations such as suboptimal
coustic windows and difﬁcult measurement of proximal
sovelocity surface area. Thus, TTE might be insufﬁcient
or diagnosis in some patients with mitral regurgitation
Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 (a) Three-dimensional multislice computed tomog-
raphy image reconstruction. (b) Quantiﬁcation of mitral
regurgitation area: blue arrow denotes the regurgitation area.
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and there is a need for new diagnostic techniques in this
area.
Multislice computed tomography (MSCT) is a promising
diagnostic tool for cardiovascular imaging. Recent advances
in MSCT allow high resolution cardiac imaging. Currently the
main application area of this technique is the evaluation of
coronary artery disease. In addition, it has recently shown
promising results in valvular imaging [2—5]. However, there
are limited data to predict the feasibility of this technique
for evaluating mitral regurgitation. There has been a lack
of diagnostic techniques for patients with mitral regurgita-
tion when TTE is technically difﬁcult or does not match the
clinical ﬁndings. Thus, we sought to evaluate the accuracy
of MSCT as an alternative imaging modality for visualizing
mitral regurgitation in comparison with TTE.
Methods
The study protocol was approved by the local ethics com-
mittee, and written informed consent was obtained from
all patients. Twenty-six consecutive patients with known
mitral regurgitation and those who were referred to the
radiology department for the evaluation of coronary artery
disease, pulmonary emboli, or congenital anomalies by MSCT
were enrolled. Exclusion criteria were renal insufﬁciency,
refusal or inability to give informed consent, severe aor-
tic valve disease or severe mitral valve stenosis, previous
adverse reaction to iodinated contrast medium, and arrhyth-
mia. The MDCT acquisition was performed in craniocaudal
direction within single breath-hold using a 16-row scanner
(Toshiba Medical Systems, Otawara, Japan). The imaging and
reconstruction parameters were as follows: detector colli-
mation 16mm× 0.75mm; voltage 120 kV; current 350mA;
gantry rotation time 0.42 s; reconstruction slice thickness
1mm; and increment 0.5mm. Patients who had a prescan
heart rate >70 bpm were given a single oral dose of 100mg
metoprolol one hour before the examination if there were
no contraindications. The ECG tracing was recorded during
acquisition for retrospective reconstruction. A 100—120ml
non-ionic contrast material was injected into the ante-
brachial vein with a ﬂow rate of 4.5ml/s using an automated
injector. Image reconstruction was performed in 5% steps
through the entire R—R interval. Multiplanar reformats
were reconstructed on a Vitrea® post-processing worksta-
tion (Vital images, Plymouth, MN, USA). Longitudinal axis
image of the mitral valve, which is similar to the parasternal
long-axis view in TTE, was constructed. Then a plane, which
is perpendicular to an imaginary line passing across the cen-
ter of the mitral valve oriﬁce, was positioned tangent to
the mitral leaﬂet tips in order to obtain the cross-sectional
image of the mitral valve oriﬁce in oblique short-axis. Mea-
surements were made in 15—25% RR by a radiologist blinded
to echocardiographic data (Fig. 1). Mitral valve calcium
score was also detected in each patient. One day after per-
forming MSCT all patients underwent TTE. The evaluation
was performed using a standard sonographic system (Vivid
7, GE Vingmed Ultrasound, Horten, Norway) equipped with
a 1.5—3.3MHz phased-array sector probe by an experienced
observer. TTE examinations included M-mode echocardiog-
raphy combined with colour Doppler examination. The vena
contracta was accepted as the narrowest portion of the
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tFor interpretation of the references to colour in this ﬁgure
egend, the reader is referred to the web version of the article.)
itral regurgitant jet downstream from the oriﬁce. Proximal
sovelocity surface area (PISA) method was used to calculate
he effective regurgitant oriﬁce area (EROA) and the regur-
itant volume. The patients were divided into three groups
ccording to mitral regurgitation severity. Mild mitral regur-
itation was deﬁned as: vena contracta width <3mm and
ROA <20mm2. Moderate mitral regurgitation was deﬁned
s: vena contracta width 3.0—6.9mm and EROA between
0mm2 and 39mm2. Severe mitral regurgitation was deﬁned
s: vena contracta width ≥7mm and EROA ≥40mm2.
tatistical analysis
ata were analyzed by MedCalc® package (version 9.4.2.0,
edCalc Software, Mariakerke, Belgium). Continuous vari-
bles are expressed as mean± SD. Comparisons of mitral
egurgitant oriﬁce area obtained by MDCT and echocar-
iography were made using paired t tests and Pearson
orrelation. Bland—Altman analysis was used to compare
wo methods. Statistical signiﬁcance was deﬁned as p < 0.05.
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Table 1 Echocardiographic and multislice computed tomography characteristics of patients.
Left atrial diameter (mm) 42.2± 5.6 (range: 34—55)
Left ventricular end-diastolic diameter (mm) 50.1± 5.5 (range: 41—61)
Left ventricular end-systolic diameter (mm) 33.3± 5.0 (range: 25—50)
Left ventricular ejection fraction (%) 63.0± 9.0 (range: 26—74)
Mitral regurgitation severity (n, %)
Mild 10 (38.5%)
Moderate 13 (50.0%)
Severe 3 (11.5%)
PISA EROA (mm2) 24.4± 16.0 (range: 6—70)
PISA regurgitant volume (ml) 37.0± 28.8 (range: 6—119)
3.6± 2.3mm (range: 0.8—9.2 mm).
23.1± 13.0 (range: 9—55)
nt oriﬁce area; CT, computed tomography.
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Figure 2 The Bland and Altman analysis of multislice com-
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MVena contracta width (mm)
CT EROA (mm2)
PISA, proximal isovelocity surface area; EROA, effective regurgita
esults
mong the 26 patients 15 (57.7%) were females, and the
ean age was 44.6± 14.1 years (range, from 21 to 76
ears); the etiology of mitral regurgitation assessed by TTE
as rheumatic in 16 (61.5%) patients and degenerative
ischemic, valve prolapsed, or ﬂail leaﬂets) in 10 (38.5%)
atients. Baseline measurements of all patients are pre-
ented in Table 1. During the MSCT examination, the mean
eart rate was 68± 8 bpm. On the basis of the TTE, 10
38.5%) patients had mild mitral regurgitation, 13 (50.0%)
ad moderately severe mitral regurgitation, and 3 (11.5%)
ad severe mitral regurgitation. The effective mitral regur-
itant oriﬁce area calculated by proximal isovelocity surface
rea at TTE ranged from 6mm2 to 70.0mm2 with a mean
f 24.4± 16.0mm2. The regurgitant volume calculated by
ISA at TTE ranged from 6ml to 119ml, with a mean of
7.0± 28.8ml. The mean vena contracta width at TTE was
.6± 2.3mm (range, from 0.8 to 9.2mm). The effective
itral regurgitant oriﬁce area at MSCT ranged from 9.0mm2
o 55mm2, with a mean of 23.1± 13.0mm2. The mean Agat-
ton score was 211.4± 315.4.
The calculated EROA was statistically similar by both TTE
nd MSCT (24.4± 16.0mm2 vs. 23.1± 13.0mm2, p = 0.311).
earson correlation analysis showed that there was a strong
orrelation between the MSCT and TTE for determining
he mitral regurgitation severity (r = 0.8917, 95% conﬁdence
nterval for r 0.7704—0.95, p < 0.0001) (Fig. 2).
The Bland and Altman analysis showed good agreement
etween MSCT and the TTE for assessing the EROA (Fig. 3).
iscussion
ur study shows that MSCT accurately determines the sever-
ty of mitral regurgitation with a good correlation to the
TE.
Mitral regurgitation is a signiﬁcant health problem both
n western and in developing countries with a wide clini-
al spectrum, ranging from asymptomatic, mild disease to
evere regurgitation with congestive heart failure [6—8].
TE, which is the major diagnostic technique for the evalu-
tion of the severity of mitral regurgitation is exquisitely
ensitive for the detection of mitral valve regurgitation,
o
a
g
ruted tomography (CT) and transthoracic echocardiography for
etermining the effective regurgitant oriﬁce area (EROA). PISA,
roximal isovelocity surface area.
nd quantitation is performed using several well-established
ethods [9—11]. TTE is an easily available method, which
s also fast and noninvasive. It also enables evaluation of
ardiac anatomy and systolic and diastolic left ventricular
unctions. There is no need for patient preparation and can
e repeated at any time. TTE has a high temporal resolution
nd therefore measurements are not affected by cardiac
rrhythmia. Besides these advantages, TTE has some signif-
cant handicaps such as poor acoustic window and operator
ependency. The image quality can be affected unfavorably
n obese patients and in patients with chronic obstructive
ung disease and in up to 10% of the patients echocardio-
raphic views cannot be obtained with enough image quality
7].
MDCT, as a new method in cardiac imaging, seems to offer
ome solutions for the difﬁculties faced in echocardiography.
DCT does not necessitate a good acoustic window and is not
perator dependent [12]. Limitations of MSCT include only
rrhythmia and radiation exposure.
During the TTE evaluation, the severity of mitral regur-
itation is determined by calculating the EROA and the
egurgitant volume [13,14]. These two main techniques
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Figure 3 (a and b) The Pearson correlation analysis showed
good agreement between multislice computed tomography (CT)
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[and transthoracic echocardiography for assessing the effective
regurgitant oriﬁce area (EROA). PISA, proximal isovelocity sur-
face area.
are calculated indirectly using the PISA method. However,
MSCT provides data to calculate the EROA directly from the
image.
To date, MSCT is primarily used for evaluating coronary
artery anatomy. However, recent studies showed that it
might be promising for evaluating valvular lesions [2,5].
MSCT exposes the patient to 6.4± 1.9mSv [15] and the
exposure to the radiation could be accepted as one of
the disadvantages of this technique. Additionally, the need
of the nephrotoxic and allergenic contrast medium and
arrhythmias are other handicaps of the method. Because
of these disadvantages, currently, a routine clinical imple-
mentation of MSCT for the evaluation of mitral regurgitation
severity cannot be recommended. However, this imaging
modality may be helpful for the evaluation of patients in
whom TTE has technical limitations.
MSCT may play a role for detecting asymptomatic mitral
regurgitation in patients who undergo MSCT for other diag-
noses (coronary artery disease or pulmonary embolism). This
point is important because severe mitral regurgitation may
cause left ventricular dysfunction even in the asymptomatic
phase.
In conclusion, the results of our study show a good
diagnostic value of MSCT for the assessment of mitral regur-
gitation. MSCT should be used as an alternative diagnostic
tool when the diagnostic accuracy of TTE is limited. In addi-
[egurgitation by multislice cardiac computed tomography239
ion coronary anatomy could be evaluated in patients for
hom mitral valve surgery is planned.
onﬂict of interest
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